Connect with us

Board of Governors

  •  Iran said on Thursday that it will reactivate the surveillance cameras of the International Atomic Energy Agency IAEA at its nuclear sites only if IAEA withdraws its accusations against Tehran Mohammad Eslami president of the Atomic Energy Organisation of Iran was also quoted by the official news agency IRNA as saying that Iran seeks to achieve a good agreement at the Vienna talks The talks would safeguard its people s interests according to the top nuclear official In June the IAEA Board of Governors passed an anti Iran resolution proposed by the U S Britain France and Germany The proposal followed the agency s reports that Tehran had not provided technically credible explanations for uranium particles found at three undeclared sites After the adoption of the IAEA resolution Iran announced a number of countermeasures including turning off the IAEA s surveillance cameras at its nuclear sites Speaking of the ongoing talks in Vienna to revive the 2015 deal Eslami expressed the hope for the U S side to show goodwill and willingness to reach an agreement and refrain from breaking its promises Iran signed a nuclear deal with world powers in July 2015 agreeing to curb its nuclear programme in return for the removal of sanctions on the country However former U S President Donald Trump pulled Washington out of the agreement and re imposed unilateral sanctions on Tehran prompting the latter to drop some of its commitments under the pact The talks on reviving the nuclear pact began in April 2021 in the Austrian capital of Vienna but were suspended in March this year because of the political differences between Tehran and Washington After almost five months delegations from the remaining signatories to the JCPOA as well as the U S are currently in Vienna for a fresh round of talks on the revival of the agreement NewsSourceCredit NAN
    Iran demands IAEA to withdraw accusations before reactivating surveillance cameras
     Iran said on Thursday that it will reactivate the surveillance cameras of the International Atomic Energy Agency IAEA at its nuclear sites only if IAEA withdraws its accusations against Tehran Mohammad Eslami president of the Atomic Energy Organisation of Iran was also quoted by the official news agency IRNA as saying that Iran seeks to achieve a good agreement at the Vienna talks The talks would safeguard its people s interests according to the top nuclear official In June the IAEA Board of Governors passed an anti Iran resolution proposed by the U S Britain France and Germany The proposal followed the agency s reports that Tehran had not provided technically credible explanations for uranium particles found at three undeclared sites After the adoption of the IAEA resolution Iran announced a number of countermeasures including turning off the IAEA s surveillance cameras at its nuclear sites Speaking of the ongoing talks in Vienna to revive the 2015 deal Eslami expressed the hope for the U S side to show goodwill and willingness to reach an agreement and refrain from breaking its promises Iran signed a nuclear deal with world powers in July 2015 agreeing to curb its nuclear programme in return for the removal of sanctions on the country However former U S President Donald Trump pulled Washington out of the agreement and re imposed unilateral sanctions on Tehran prompting the latter to drop some of its commitments under the pact The talks on reviving the nuclear pact began in April 2021 in the Austrian capital of Vienna but were suspended in March this year because of the political differences between Tehran and Washington After almost five months delegations from the remaining signatories to the JCPOA as well as the U S are currently in Vienna for a fresh round of talks on the revival of the agreement NewsSourceCredit NAN
    Iran demands IAEA to withdraw accusations before reactivating surveillance cameras
    Foreign2 months ago

    Iran demands IAEA to withdraw accusations before reactivating surveillance cameras

    Iran said on Thursday that it will reactivate the surveillance cameras of the International Atomic Energy Agency (IAEA) at its nuclear sites only if IAEA withdraws its accusations against Tehran.

    Mohammad Eslami, president of the Atomic Energy Organisation of Iran, was also quoted by the official news agency, IRNA as saying that Iran seeks to achieve a good agreement at the Vienna talks.

    The talks would safeguard its people’s interests, according to the top nuclear official.

    In June, the IAEA Board of Governors passed an anti-Iran resolution proposed by the U.

    S., Britain, France and Germany.

    The proposal followed the agency’s reports that Tehran had not provided technically credible explanations for uranium particles found at three undeclared sites.

    After the adoption of the IAEA resolution, Iran announced a number of countermeasures, including turning off the IAEA’s surveillance cameras at its nuclear sites.

    Speaking of the ongoing talks in Vienna to revive the 2015 deal, Eslami expressed the hope for the U.

    S. side to show goodwill and willingness to reach an agreement, and refrain from breaking its promises.

    Iran signed a nuclear deal with world powers in July 2015, agreeing to curb its nuclear programme in return for the removal of sanctions on the country.

    However, former U.

    S. President, Donald Trump pulled Washington out of the agreement and re-imposed unilateral sanctions on Tehran, prompting the latter to drop some of its commitments under the pact.

    The talks on reviving the nuclear pact began in April 2021 in the Austrian capital of Vienna but were suspended in March this year because of the political differences between Tehran and Washington.

    After almost five months, delegations from the remaining signatories to the JCPOA, as well as the U.

    S., are currently in Vienna for a fresh round of talks on the revival of the agreement.


    NewsSourceCredit: NAN

  •   Kenya s effort to ensure access to the safe and ethical use of human cells tissues and organs will be updated with the establishment of the Kenya Tissue and Transplant Authority by President Uhuru Kenyatta The authority which was established by means of a special bulletin dated August 1 will succeed the Department of the National Service of Blood Transfusion Tissues and Human Organ Transplantation It will be necessary to ensure the safety biosafety and welfare of donors and recipients in medical services related to medical products of human origin by establishing and maintaining systems that meet legal and safety requirements The authority will be tasked with regulating all services related to the transplantation of human cells tissues and organs in accordance with the Health Act of 2017 registering and licensing facilities and establishments dealing with human cells tissues and organs and transplant services maintain a registry of transplant service providers donors and recipients as well as establish an equitable mechanism for the matching and allocation of cells tissues and organs It will also oversee the implementation of policies guidelines procedures and standards related to human tissues and organs provide support services for transfusion and transplant systems including testing pooling typing storage processing distribution manufacturing and quality control develop a national emergency response mechanism including maintaining strategic stockpiles of human tissues and organs mobilizing educating and raising public awareness to encourage voluntary cell tissue and organ donations and collaborating with other established organ exchange organizations other countries for the exchange of tissues and organs Other functions include conducting and collaborating with other interested parties in the conduct of research on human cells tissues and organs and related services advising the Secretary of the Cabinet of Health the national and county already all interested parties on ethical legal and clinical issues related to human tissue and cell services and organ transplantation and other functions determined by the Board with the approval of the Secretary of the Cabinet In carrying out its mandate the authority has been empowered to establish and maintain ties with relevant regulatory and service agencies on matters related to human organ tissue and cell medical services issue and enforce instructions to ensure compliance inspect hospitals periodically to review transplant quality and follow up care for people who have had transplants and people who have organs removed It may also summon any person in possession of any information relating to violations enter search and inspect any location suspected of being in the course of unauthorized removal procurement or transplantation of human cells organs or tissues or order the presentation of any document or material object suspected of being used in connection with the unauthorized removal procurement or transplantation of human cells organs or tissues The authority shall have a board composed of a non executive Chairman appointed by the President the Principal Secretary of the Ministry of Health responsible for finance or his representative appointed in writing the Attorney General or his representative appointed in writing a person other than Governor nominated by the Board of Governors three other members who are not civil servants appointed by the Cabinet Secretary on the basis of gender disability regional balance and their knowledge and experience of matters related to hematology pathology transplant medicine finance management economics law or any other relevant field The CEO shall be an ex officio member of the Board The formation of the authority comes amid increased investments in modern blood processing storage and testing equipment access to safe organs and transplant services and distribution mechanisms across the country In order to institutionalize and safeguard the gains made Kenya has developed the Kenya Policy on Donations Transfusions and Transplantation of Medical Products of Human Origin the first integrated policy on blood cells tissues and organs in Eastern Central and Southern Africa To address the challenge of outdated equipment and resources in the management of blood cells tissues and organs the Ministry of Health has invested in the digitalization of health by leveraging technology with the recent launch of the Blood Bank Information System of Kenya Damu KE The system ensures the efficiency and safety of related products and in building capacity for the health system to respond to critical needs The system has been implemented in all the Regional Blood Transfusion Centers and in the county satellites and is operational in the national reference hospitals As part of the medium term Plan 4 the Ministry of Health has prioritized the development of a Kenya Blood and Organ Centre The Center will house a strategic blood product reserve bank to eliminate shortages during emergencies with a nationally coordinated deployment mechanism It will include an organ and stem cell bank for a repository of available products and thus facilitate the implementation of an organ matching and allocation scheme In an effort to safeguard the quality of related products the first Blood and Organs Reference Laboratory will be established to serve East and Central Africa in addition to investing in the training of human resources with the capacity for medicine and research specialized in transfusions and transplants
    Sea change as President Kenyatta creates Kenya Tissue and Transplant Authority
      Kenya s effort to ensure access to the safe and ethical use of human cells tissues and organs will be updated with the establishment of the Kenya Tissue and Transplant Authority by President Uhuru Kenyatta The authority which was established by means of a special bulletin dated August 1 will succeed the Department of the National Service of Blood Transfusion Tissues and Human Organ Transplantation It will be necessary to ensure the safety biosafety and welfare of donors and recipients in medical services related to medical products of human origin by establishing and maintaining systems that meet legal and safety requirements The authority will be tasked with regulating all services related to the transplantation of human cells tissues and organs in accordance with the Health Act of 2017 registering and licensing facilities and establishments dealing with human cells tissues and organs and transplant services maintain a registry of transplant service providers donors and recipients as well as establish an equitable mechanism for the matching and allocation of cells tissues and organs It will also oversee the implementation of policies guidelines procedures and standards related to human tissues and organs provide support services for transfusion and transplant systems including testing pooling typing storage processing distribution manufacturing and quality control develop a national emergency response mechanism including maintaining strategic stockpiles of human tissues and organs mobilizing educating and raising public awareness to encourage voluntary cell tissue and organ donations and collaborating with other established organ exchange organizations other countries for the exchange of tissues and organs Other functions include conducting and collaborating with other interested parties in the conduct of research on human cells tissues and organs and related services advising the Secretary of the Cabinet of Health the national and county already all interested parties on ethical legal and clinical issues related to human tissue and cell services and organ transplantation and other functions determined by the Board with the approval of the Secretary of the Cabinet In carrying out its mandate the authority has been empowered to establish and maintain ties with relevant regulatory and service agencies on matters related to human organ tissue and cell medical services issue and enforce instructions to ensure compliance inspect hospitals periodically to review transplant quality and follow up care for people who have had transplants and people who have organs removed It may also summon any person in possession of any information relating to violations enter search and inspect any location suspected of being in the course of unauthorized removal procurement or transplantation of human cells organs or tissues or order the presentation of any document or material object suspected of being used in connection with the unauthorized removal procurement or transplantation of human cells organs or tissues The authority shall have a board composed of a non executive Chairman appointed by the President the Principal Secretary of the Ministry of Health responsible for finance or his representative appointed in writing the Attorney General or his representative appointed in writing a person other than Governor nominated by the Board of Governors three other members who are not civil servants appointed by the Cabinet Secretary on the basis of gender disability regional balance and their knowledge and experience of matters related to hematology pathology transplant medicine finance management economics law or any other relevant field The CEO shall be an ex officio member of the Board The formation of the authority comes amid increased investments in modern blood processing storage and testing equipment access to safe organs and transplant services and distribution mechanisms across the country In order to institutionalize and safeguard the gains made Kenya has developed the Kenya Policy on Donations Transfusions and Transplantation of Medical Products of Human Origin the first integrated policy on blood cells tissues and organs in Eastern Central and Southern Africa To address the challenge of outdated equipment and resources in the management of blood cells tissues and organs the Ministry of Health has invested in the digitalization of health by leveraging technology with the recent launch of the Blood Bank Information System of Kenya Damu KE The system ensures the efficiency and safety of related products and in building capacity for the health system to respond to critical needs The system has been implemented in all the Regional Blood Transfusion Centers and in the county satellites and is operational in the national reference hospitals As part of the medium term Plan 4 the Ministry of Health has prioritized the development of a Kenya Blood and Organ Centre The Center will house a strategic blood product reserve bank to eliminate shortages during emergencies with a nationally coordinated deployment mechanism It will include an organ and stem cell bank for a repository of available products and thus facilitate the implementation of an organ matching and allocation scheme In an effort to safeguard the quality of related products the first Blood and Organs Reference Laboratory will be established to serve East and Central Africa in addition to investing in the training of human resources with the capacity for medicine and research specialized in transfusions and transplants
    Sea change as President Kenyatta creates Kenya Tissue and Transplant Authority
    Africa2 months ago

    Sea change as President Kenyatta creates Kenya Tissue and Transplant Authority

    Kenya's effort to ensure access to the safe and ethical use of human cells, tissues and organs will be updated with the establishment of the Kenya Tissue and Transplant Authority by President Uhuru Kenyatta.

    The authority, which was established by means of a special bulletin dated August 1, will succeed the Department of the National Service of Blood Transfusion, Tissues and Human Organ Transplantation.

    It will be necessary to ensure the safety, biosafety and welfare of donors and recipients in medical services related to medical products of human origin by establishing and maintaining systems that meet legal and safety requirements.

    The authority will be tasked with regulating all services related to the transplantation of human cells, tissues and organs in accordance with the Health Act of 2017, registering and licensing facilities and establishments dealing with human cells, tissues and organs and transplant services, maintain a registry of transplant service providers, donors, and recipients, as well as establish an equitable mechanism for the matching and allocation of cells, tissues, and organs.

    It will also oversee the implementation of policies, guidelines, procedures, and standards related to human tissues and organs, provide support services for transfusion and transplant systems, including testing, pooling, typing, storage, processing, distribution, manufacturing, and quality control, develop a national emergency response mechanism, including maintaining strategic stockpiles of human tissues and organs, mobilizing, educating and raising public awareness to encourage voluntary cell, tissue and organ donations and collaborating with other established organ exchange organizations other countries, for the exchange of tissues and organs Other functions include conducting and collaborating with other interested parties in the conduct of research on human cells, tissues and organs and related services, advising the Secretary of the Cabinet of Health, the national and county already all interested parties on ethical, legal and clinical issues related to human tissue and cell services.

    and organ transplantation and other functions determined by the Board, with the approval of the Secretary of the Cabinet.

    In carrying out its mandate, the authority has been empowered to establish and maintain ties with relevant regulatory and service agencies on matters related to human organ, tissue and cell medical services, issue and enforce instructions to ensure compliance, inspect hospitals periodically to review transplant quality and follow-up care for people who have had transplants and people who have organs removed.

    It may also summon any person in possession of any information relating to violations, enter, search, and inspect any location suspected of being in the course of unauthorized removal, procurement, or transplantation of human cells, organs, or tissues, or order the presentation of any document or material object suspected of being used in connection with the unauthorized removal, procurement, or transplantation of human cells, organs, or tissues.

    The authority shall have a board composed of a non-executive Chairman appointed by the President, the Principal Secretary of the Ministry of Health responsible for finance, or his representative, appointed in writing, the Attorney General or his representative, appointed in writing, a person , other than Governor, nominated by the Board of Governors, three other members, who are not civil servants, appointed by the Cabinet Secretary on the basis of gender, disability, regional balance, and their knowledge and experience of matters related to hematology, pathology, transplant medicine, finance, management, economics, law or any other relevant field.

    The CEO shall be an ex officio member of the Board.

    The formation of the authority comes amid increased investments in modern blood processing, storage and testing equipment, access to safe organs and transplant services and distribution mechanisms across the country.

    In order to institutionalize and safeguard the gains made, Kenya has developed the Kenya Policy on Donations, Transfusions and Transplantation of Medical Products of Human Origin, the first integrated policy on blood, cells, tissues and organs in Eastern, Central and Southern Africa.

    .

    To address the challenge of outdated equipment and resources in the management of blood, cells, tissues and organs, the Ministry of Health has invested in the digitalization of health by leveraging technology with the recent launch of the Blood Bank Information System of Kenya: Damu-KE.

    The system ensures the efficiency and safety of related products and in building capacity for the health system to respond to critical needs.

    The system has been implemented in all the Regional Blood Transfusion Centers and in the county satellites and is operational in the national reference hospitals.

    As part of the medium-term Plan 4, the Ministry of Health has prioritized the development of a Kenya Blood and Organ Centre.

    The Center will house a strategic blood product reserve bank to eliminate shortages during emergencies with a nationally coordinated deployment mechanism.

    It will include an organ and stem cell bank for a repository of available products and thus facilitate the implementation of an organ matching and allocation scheme.

    In an effort to safeguard the quality of related products, the first Blood and Organs Reference Laboratory will be established to serve East and Central Africa, in addition to investing in the training of human resources with the capacity for medicine and research specialized in transfusions and transplants.